IGF1 and medulloblastoma: In our CSF samples for patients all >6mo, high risk medulloblastoma patient IGF1 levels were significantly higher than ALL patient IGF1 levels (9.56+/−4.49 versus 3.47+/−2.09, p = 0.04) (Table 1).